Insider Trading activities of Blueprint Medicines Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Blueprint Medicines Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Blueprint Medicines Corp since year 2005. Table 2 shows the detailed insider transactions of Blueprint Medicines Corp since 2005. The reporting company's ticker symbol is BPMC. The reporting company's CIK number is 1597264.
The total value of stock buying since 2005 is $2,250,000.
The total value of stock sales since 2005 is $75,276,865.
The total value of stock option exercises since 2005 is $785,094.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Blueprint Medicines Corp (BPMC).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 5,449 $362,102 5,449 $88,709
2017-09 0 $0 8,856 $531,550 6,356 $103,475
2017-08 0 $0 35,000 $1,724,165 5,000 $44,000
2017-07 0 $0 14,765 $802,731 7,265 $118,274
2017-06 0 $0 68,857 $3,451,647 16,357 $191,491
2017-03 0 $0 140,214 $5,634,137 12,714 $206,983
2017-02 0 $0 1,000,000 $35,275,000 0 $0
2016-12 0 $0 106,489 $3,002,350 0 $0
2016-11 0 $0 1,700 $51,068 0 $0
2016-10 0 $0 21,800 $654,436 0 $0
2016-08 0 $0 17,000 $391,510 0 $0
2016-06 0 $0 17,000 $340,510 0 $0
2016-04 0 $0 51,725 $1,044,462 0 $0
2016-03 0 $0 0 $0 19,167 $32,162
2015-12 0 $0 31,119 $779,603 0 $0
2015-11 0 $0 1,033,648 $21,231,594 0 $0
2015-05 125,000 $2,250,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Blueprint Medicines Corp insiders (BPMC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-05 Haviland Kate (Chief Business Officer) Sale 5,449 66.45 362,102
2017-10-05 Haviland Kate (Chief Business Officer) Option Ex 5,449 16.28 88,709
2017-09-18 Haviland Kate (Chief Business Officer) Sale 6,356 60.03 381,550
2017-09-18 Haviland Kate (Chief Business Officer) Option Ex 6,356 16.28 103,475
2017-09-18 Lynch Daniel Sale 2,500 60.00 150,000
2017-08-09 Boral Anthony L. (Chief Medical Officer) Sale 5,000 48.43 242,165
2017-08-09 Boral Anthony L. (Chief Medical Officer) Option Ex 5,000 8.80 44,000
2017-08-08 Albers Jeffrey W. (CEO and President) Sale 10,000 50.70 507,000
2017-08-07 Albers Jeffrey W. (CEO and President) Sale 20,000 48.75 975,000
2017-07-05 Haviland Kate (Chief Business Officer) Sale 7,265 53.65 389,781
2017-07-05 Haviland Kate (Chief Business Officer) Option Ex 7,265 16.28 118,274
2017-07-05 Lynch Daniel Sale 7,500 55.06 412,950
2017-06-28 Haviland Kate (Chief Business Officer) Sale 6,357 50.00 317,850
2017-06-28 Haviland Kate (Chief Business Officer) Option Ex 6,357 16.28 103,491
2017-06-28 Albers Jeffrey W. (CEO and President) Sale 20,000 50.18 1,003,540
2017-06-28 Boral Anthony L. (Chief Medical Officer) Sale 10,000 50.11 501,130
2017-06-28 Boral Anthony L. (Chief Medical Officer) Option Ex 10,000 8.80 88,000
2017-06-28 Lynch Daniel Sale 32,500 50.13 1,629,127
2017-03-16 Levin Mark J (10% Owner) Sale 30,000 41.15 1,234,350
2017-03-14 Haviland Kate (Chief Business Officer) Sale 12,714 40.01 508,687
2017-03-14 Haviland Kate (Chief Business Officer) Option Ex 12,714 16.28 206,983
2017-03-14 Lydon Nicholas Sale 70,000 39.89 2,792,300
2017-03-14 Albers Jeffrey W. (CEO and President) Sale 20,000 39.90 797,900
2017-03-14 Lynch Daniel Sale 7,500 40.12 300,900
2017-02-07 Tepper Robert I (10% Owner) Sale 1,000,000 35.27 35,275,000
2016-12-19 Starr Kevin P (10% Owner) Sale 106,489 28.19 3,002,350
2016-11-01 Lynch Daniel Sale 1,700 30.04 51,068
2016-10-13 Lynch Daniel Sale 21,800 30.02 654,436
2016-08-08 Albers Jeffrey W. (CEO and President) Sale 17,000 23.03 391,510
2016-06-03 Albers Jeffrey W. (CEO and President) Sale 17,000 20.03 340,510
2016-04-13 Lengauer Christoph (Chief Scientific Officer) Sale 15,872 20.01 317,598
2016-04-12 Lengauer Christoph (Chief Scientific Officer) Sale 10,316 20.01 206,423
2016-04-11 Lengauer Christoph (Chief Scientific Officer) Sale 8,537 20.30 173,301
2016-04-06 Albers Jeffrey W. (CEO and President) Sale 17,000 20.42 347,140
2016-03-24 Lengauer Christoph (Chief Scientific Officer) Option Ex 19,167 1.68 32,162
2015-12-17 Lengauer Christoph (Chief Scientific Officer) Sale 6,463 25.14 162,479
2015-12-16 Lengauer Christoph (Chief Scientific Officer) Sale 24,156 25.03 604,624
2015-12-15 Lengauer Christoph (Chief Scientific Officer) Sale 500 25.00 12,500
2015-11-27 Fmr Llc (Other) Sale 57,819 21.91 1,267,103
2015-11-25 Fmr Llc (Other) Sale 229,596 21.23 4,873,175
2015-11-24 Fmr Llc (Other) Sale 161,271 20.14 3,247,997
2015-11-23 Fmr Llc (Other) Sale 85,300 20.14 1,717,515
2015-11-20 Fmr Llc (Other) Sale 104,272 20.09 2,095,345
2015-11-19 Fmr Llc (Other) Sale 155,894 19.86 3,096,054
2015-11-18 Fmr Llc (Other) Sale 81,324 19.76 1,607,206
2015-11-17 Fmr Llc (Other) Sale 27,490 20.57 565,469
2015-11-16 Fmr Llc (Other) Sale 28,684 21.25 609,391
2015-11-10 Albers Jeffrey W. (CEO and President) Sale 7,000 21.87 153,090
2015-11-03 Lengauer Christoph (Chief Scientific Officer) Sale 36,734 20.98 770,679
2015-11-02 Albers Jeffrey W. (CEO and President) Sale 10,000 21.02 210,200
2015-11-02 Lengauer Christoph (Chief Scientific Officer) Sale 48,264 21.10 1,018,370
2015-05-05 Fmr Llc (Other) Buy 125,000 18.00 2,250,000

Insider trading activities including stock purchases, stock sales, and option exercises of BPMC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Blueprint Medicines Corp (symbol BPMC, CIK number 1597264) see the Securities and Exchange Commission (SEC) website.